The Ellipsoid Zone Is a Structural Biomarker for Visual Outcomes in Diabetic Macular Edema and Macular Hole Management

Overview

Journal Vision (Basel)

Date 2025 Jan 23

PMID 39846620

Authors

Shivani Chaturvedi

Amisha Paul

Samya Singh

Levent Akduman

Sandeep Saxena

Affiliations

Soon will be listed here.

Abstract

Objectives: The goal was to study the ellipsoid zone (EZ) as a structural biomarker for final visual outcomes after pharmacological intervention in center-involving diabetic macular edema (DME) and surgical intervention for full-thickness macular holes (FTMHs).

Methods: This was a tertiary care center-based retrospective study. After sample size calculations, data from 64 consecutive cases were collected, with subjects aged between 40 and 60 years. Thirty-two cases of DME with anti-vascular endothelial growth factor (VEGF) therapy and 32 cases of FTMHs with successful macular hole surgery (MHS) were studied. Spectral-domain optical coherence tomography (SD-OCT) data were collected. Measurements of EZ defects documented at the time of presentation and 12 weeks after intervention were analyzed using the caliper function of the machine. EZ restoration was graded, and a Pearson correlation analysis was performed.

Results: Mean logMAR VA decreased after intravitreal therapy (IVT) from 1.12 ± 0.22 pre-intervention to 0.81 ± 0.41 post-intervention and after MHS, from 1.05 + 0.25 to 0.62 + 0.11 ( < 0.001). EZ disruption reduced from 73.4% to 19.4% after IVT and from 67% to 19.3% after MHS. DME and MHS postoperative visual acuity and residual EZ defect were observed to have a statistically significant linear correlation (r = 0.794, < 0.001 and r = 0.894, < 0.001, respectively). The EZ was found to be an excellent structural biomarker for final BCVA (area under curve = 0.95 for DME and 1.00 for MHS).

Conclusion: Notable EZ restoration results were obtained from pharmacological and surgical interventions. The EZ proves to be a critical structural biomarker for predicting visual outcomes in center-involving DME and MHS.

References

Saxena S, Caprnda M, Ruia S, Prasad S, Ankita , Fedotova J . Spectral domain optical coherence tomography based imaging biomarkers for diabetic retinopathy. Endocrine. 2019; 66(3):509-516. DOI: 10.1007/s12020-019-02093-7. View

Ullrich S, Haritoglou C, Gass C, Schaumberger M, Ulbig M, Kampik A . Macular hole size as a prognostic factor in macular hole surgery. Br J Ophthalmol. 2002; 86(4):390-3. PMC: 1771090. DOI: 10.1136/bjo.86.4.390. View

Mori Y, Suzuma K, Uji A, Ishihara K, Yoshitake S, Fujimoto M . Restoration of foveal photoreceptors after intravitreal ranibizumab injections for diabetic macular edema. Sci Rep. 2016; 6:39161. PMC: 5155247. DOI: 10.1038/srep39161. View

Forsaa V, Lindtjorn B, Kvaloy J, Froystein T, Krohn J . Epidemiology and morphology of full-thickness macular holes. Acta Ophthalmol. 2017; 96(4):397-404. DOI: 10.1111/aos.13618. View

Sen P, Bhargava A, Vijaya L, George R . Prevalence of idiopathic macular hole in adult rural and urban south Indian population. Clin Exp Ophthalmol. 2008; 36(3):257-60. DOI: 10.1111/j.1442-9071.2008.01715.x. View

Ooka E, Mitamura Y, Baba T, Kitahashi M, Oshitari T, Yamamoto S . Foveal microstructure on spectral-domain optical coherence tomographic images and visual function after macular hole surgery. Am J Ophthalmol. 2011; 152(2):283-290.e1. DOI: 10.1016/j.ajo.2011.02.001. View

Lee M, Kim T, Song Y, Baek S, Lee Y . Changes in each retinal layer and ellipsoid zone recovery after full-thickness macular hole surgery. Sci Rep. 2021; 11(1):11351. PMC: 8167100. DOI: 10.1038/s41598-021-90955-4. View

Saxena S, Ruia S, Prasad S, Jain A, Mishra N, Natu S . INCREASED SERUM LEVELS OF UREA AND CREATININE ARE SURROGATE MARKERS FOR DISRUPTION OF RETINAL PHOTORECEPTOR EXTERNAL LIMITING MEMBRANE AND INNER SEGMENT ELLIPSOID ZONE IN TYPE 2 DIABETES MELLITUS. Retina. 2017; 37(2):344-349. DOI: 10.1097/IAE.0000000000001163. View

Priglinger S, Wolf A, Kreutzer T, Kook D, Hofer A, Strauss R . Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Retina. 2007; 27(8):1004-12. DOI: 10.1097/IAE.0b013e3180ed458d. View

10.

Jain A, Saxena S, Khanna V, Shukla R, Meyer C . Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol Vis. 2013; 19:1760-8. PMC: 3733909. View

11.

Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N . Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol. 2011; 153(4):710-7, 717.e1. DOI: 10.1016/j.ajo.2011.08.041. View

12.

Rosenfeld P, Fung A, Puliafito C . Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2005; 36(4):336-9. View

13.

Wang S, Xu L, Jonas J . Prevalence of full-thickness macular holes in urban and rural adult Chinese: the Beijing Eye Study. Am J Ophthalmol. 2006; 141(3):589-91. DOI: 10.1016/j.ajo.2005.10.021. View

14.

Bottoni F, de Angelis S, Luccarelli S, Cigada M, Staurenghi G . The dynamic healing process of idiopathic macular holes after surgical repair: a spectral-domain optical coherence tomography study. Invest Ophthalmol Vis Sci. 2011; 52(7):4439-46. DOI: 10.1167/iovs.10-6732. View

15.

Panozzo G, Cicinelli M, Augustin A, Battaglia Parodi M, Cunha-Vaz J, Guarnaccia G . An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification. Eur J Ophthalmol. 2019; 30(1):8-18. DOI: 10.1177/1120672119880394. View

16.

Campos A, Campos E, do Carmo A, Caramelo F, Martins J, Sousa J . Evaluation of markers of outcome in real-world treatment of diabetic macular edema. Eye Vis (Lond). 2018; 5:27. PMC: 6198537. DOI: 10.1186/s40662-018-0119-9. View

17.

Smiddy W, Feuer W, Cordahi G . Internal limiting membrane peeling in macular hole surgery. Ophthalmology. 2001; 108(8):1471-6; discussion 1477-8. DOI: 10.1016/s0161-6420(00)00645-x. View

18.

Kitao M, Wakabayashi T, Nishida K, Sakaguchi H, Nishida K . Long-term reconstruction of foveal microstructure and visual acuity after idiopathic macular hole repair: three-year follow-up study. Br J Ophthalmol. 2018; 103(2):238-244. DOI: 10.1136/bjophthalmol-2017-311689. View

19.

Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I . Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest. 1998; 101(6):1219-24. PMC: 508675. DOI: 10.1172/JCI1277. View

20.

Omri S, Omri B, Savoldelli M, Jonet L, Thillaye-Goldenberg B, Thuret G . The outer limiting membrane (OLM) revisited: clinical implications. Clin Ophthalmol. 2010; 4:183-95. PMC: 2861922. DOI: 10.2147/opth.s5901. View